CN101454308B - 制备杂环衍生物的方法 - Google Patents

制备杂环衍生物的方法 Download PDF

Info

Publication number
CN101454308B
CN101454308B CN200780019578XA CN200780019578A CN101454308B CN 101454308 B CN101454308 B CN 101454308B CN 200780019578X A CN200780019578X A CN 200780019578XA CN 200780019578 A CN200780019578 A CN 200780019578A CN 101454308 B CN101454308 B CN 101454308B
Authority
CN
China
Prior art keywords
alkyl
alkoxy
substituted
compounds
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200780019578XA
Other languages
English (en)
Chinese (zh)
Other versions
CN101454308A (zh
Inventor
瑟吉奥·巴奇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of CN101454308A publication Critical patent/CN101454308A/zh
Application granted granted Critical
Publication of CN101454308B publication Critical patent/CN101454308B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
CN200780019578XA 2006-04-03 2007-03-30 制备杂环衍生物的方法 Expired - Fee Related CN101454308B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0607899.2A GB0607899D0 (en) 2006-04-03 2006-04-03 Process for preparing heterocyclic derivatives
GB0607899.2 2006-04-03
PCT/EP2007/053118 WO2007113261A1 (en) 2006-04-03 2007-03-30 Process for preparing heterocyclic derivatives

Publications (2)

Publication Number Publication Date
CN101454308A CN101454308A (zh) 2009-06-10
CN101454308B true CN101454308B (zh) 2013-05-08

Family

ID=36581002

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200780019578XA Expired - Fee Related CN101454308B (zh) 2006-04-03 2007-03-30 制备杂环衍生物的方法

Country Status (18)

Country Link
US (2) US20070232808A1 (enExample)
EP (1) EP2007747B1 (enExample)
JP (1) JP5167242B2 (enExample)
KR (1) KR101411124B1 (enExample)
CN (1) CN101454308B (enExample)
AU (1) AU2007233744B2 (enExample)
BR (1) BRPI0710049A2 (enExample)
CA (1) CA2648089A1 (enExample)
CR (1) CR10351A (enExample)
EA (1) EA017304B1 (enExample)
ES (1) ES2443219T3 (enExample)
GB (1) GB0607899D0 (enExample)
IL (1) IL194389A0 (enExample)
MA (1) MA30354B1 (enExample)
MX (1) MX2008012876A (enExample)
NO (1) NO20084414L (enExample)
WO (1) WO2007113261A1 (enExample)
ZA (1) ZA200808107B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3995C2 (ro) * 2009-05-11 2010-07-31 Государственный Университет Молд0 Utilizare a di(µ-Ofenoxi)-di{[2-(4-aminobenzensulfamido)-5-etil-1,3,4-tiadiazol]-3,5-dibromosalicilidentiosemicarbazonato(-1)-cupru} în calitate de inhibitor al proliferării celulelor T-47D ale cancerului mamar
IT201700041723A1 (it) 2017-04-14 2018-10-14 Italfarmaco Spa Nuovi inibitori selettivi di HDAC6
CN106866657A (zh) * 2017-04-25 2017-06-20 成都倍特药业有限公司 一种麦角新碱的制备方法
US9862675B1 (en) 2017-07-05 2018-01-09 King Fahd University Of Petroleum And Minerals Method of N-formylating amines with a phosphonic anhydride
JP2023537052A (ja) 2020-08-07 2023-08-30 イタルファルマコ ソシエタ ペル アチオニ 新規オキサジアゾール系の選択的hdac6阻害剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020032238A1 (en) * 2000-07-08 2002-03-14 Henning Priepke Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments
DE10033337A1 (de) * 2000-07-08 2002-01-17 Boehringer Ingelheim Pharma Biphenylcarbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
AU1697502A (en) * 2000-10-20 2002-04-29 Rhodia Acetow Gmbh Highly compressed filter tow bales
CA2557115C (en) 2004-02-23 2012-10-02 Glaxo Group Limited Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors
GB0517193D0 (en) 2005-08-22 2005-09-28 Glaxo Group Ltd Novel use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Abdellah Ech-Chahad, et al..An expeditious hydroxyamidation of carboxylic acids.《Tetrahedron Letters》.2005,第46卷第5113-5115页. *

Also Published As

Publication number Publication date
KR101411124B1 (ko) 2014-06-25
JP5167242B2 (ja) 2013-03-21
US20100048895A1 (en) 2010-02-25
US20070232808A1 (en) 2007-10-04
CN101454308A (zh) 2009-06-10
JP2009532428A (ja) 2009-09-10
EP2007747B1 (en) 2013-11-20
AU2007233744B2 (en) 2012-09-06
EP2007747A1 (en) 2008-12-31
WO2007113261A1 (en) 2007-10-11
CA2648089A1 (en) 2007-10-11
BRPI0710049A2 (pt) 2011-08-02
AU2007233744A1 (en) 2007-10-11
IL194389A0 (en) 2009-08-03
EA200870405A1 (ru) 2009-04-28
NO20084414L (no) 2008-10-28
KR20080108328A (ko) 2008-12-12
GB0607899D0 (en) 2006-05-31
US7838680B2 (en) 2010-11-23
MX2008012876A (es) 2008-10-13
EA017304B1 (ru) 2012-11-30
CR10351A (es) 2008-10-29
MA30354B1 (fr) 2009-04-01
ZA200808107B (en) 2009-10-28
ES2443219T3 (es) 2014-02-18

Similar Documents

Publication Publication Date Title
AU2019201352B2 (en) Bromodomain inhibitors
AU2015271030B2 (en) Radiolabelled derivatives of a 2-amino-6-fluoro-n-[5-fluoro-pyridin-3-yl]- pyrazolo [1,5-a] pyrimidin-3-carboxamide compound useful as ATR kinase inhibitor, the preparation of said compound and different solid forms thereof
KR100274104B1 (ko) 포스포디에스테라제 억제제로서의 피리도[2,3-d]피리미딘 유도체, 이의 제조방법 및 이를 함유하는 약제학적 조성물
CA2272460C (fr) Derives de la pyridin-2-yl-methylamine, leur procede de preparation et leur application comme medicaments
EP3704106B1 (en) Alkene compounds as farnesoid x receptor modulators
JP2002537298A (ja) ピリジン化合物およびその医薬用途
JPWO2005061490A1 (ja) Hivインテグラーゼ阻害活性を有するヒドロキシピリミジノン誘導体
JPH11513679A (ja) 薬剤活性キナゾリン化合物
CN101454308B (zh) 制备杂环衍生物的方法
TW202214602A (zh) Il-17之小分子調節劑
AU619111B2 (en) Antirhinoviral (thio) morpholinyl and piperazinyl alkylphenol ethers
WO2008085117A1 (en) Pyridine compounds and their use as p2y12 antagonists.
WO2014089140A1 (en) Process for making reverse transcriptase inhibitors
JP2025505830A (ja) Rad51阻害剤としての新規二環式化合物
MX2008016548A (es) Nuevos analogos de piridina.
EP4578857A1 (en) Cryptolepine salt derivative, and preparation method therefor and use thereof
HK40080347A (en) Bromodomain inhibitors
MXPA05006588A (es) Compuestos de pirazol como derivados antagonistas del receptor de la integrina.
RU2557659C1 (ru) Способ получения амидразонов 4-r-1,2,5-оксадиазол-3-карбоновой кислоты
HK1236191A1 (en) Radiolabelled derivatives of a 2-amino-6-fluoro-n-[5-fluoro-pyridin-3-yl]- pyrazolo[1,5-a]pyrimidin-3-carboxamide compound useful as atr kinase inhibitor, the preparation of said compound and different solid forms thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130508

Termination date: 20170330

CF01 Termination of patent right due to non-payment of annual fee